iRadimed Corporation

IRMD Healthcare Medical Devices

iRadimed Corporation’s revenue for fiscal 2025 (year ended December 2025) was $83.8 million, up 14.4% from fiscal 2024.

Revenue
+14.2%
EPS
+15.9%
Free cash flow
+18.6%

Quarter to September 2026, against a year earlier

86.17 0.63 +0.74%
Market cap
$1.1B
P/E
45.6×
Fwd P/E
39.6×
Dividend yield
0.89%
F-score
6/9
Altman Z
55.62
Beneish M
−2.55
Dividend safety
40/100
Older periods Dec '25 Mar '26 Jun '26 Sep '26
Piotroski F-Score

+8 more TTM periods

6 6 5 6
ROE
24.78% 25.04% 23.52% 23.42%
ROA
21.71% 21.85% 20.82% 20.34%
ROIC
37.60% 41.46% 40.36% 41.79%
Return on Tangible Assets
23.69% 23.96% 22.65% 22.51%
Average Days of Receivables
59.52 56.75 55.77 55.87
Free Cash Flow per Share
1.30 1.88 1.92 2.00
Free Cash Flow
16.53 23.97 24.55 25.61
Other line items

Show all line items

Columns are period end dates · fundamentals updated 6 Nov 2026